1. Home
  2. SON vs AMRX Comparison

SON vs AMRX Comparison

Compare SON & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$47.84

Market Cap

5.4B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.01

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
AMRX
Founded
1899
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.2B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
SON
AMRX
Price
$47.84
$17.01
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$60.13
$15.60
AVG Volume (30 Days)
912.2K
1.6M
Earning Date
04-21-2026
05-01-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
157.89
EPS
0.68
0.37
Revenue
$7,518,753,000.00
N/A
Revenue This Year
$0.10
$4.48
Revenue Next Year
$1.82
$7.13
P/E Ratio
$71.16
$46.62
Revenue Growth
41.72
N/A
52 Week Low
$38.65
$9.49
52 Week High
$60.67
$19.26

Technical Indicators

Market Signals
Indicator
SON
AMRX
Relative Strength Index (RSI) 24.58 39.61
Support Level $46.53 $16.61
Resistance Level $49.80 $18.19
Average True Range (ATR) 1.71 0.44
MACD -1.03 -0.12
Stochastic Oscillator 4.70 2.41

Price Performance

Historical Comparison
SON
AMRX

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: